Anumana vs Bayesian Health

Anumana's ECG-AI reads a standard 12-lead ECG and flags low ejection fraction (K250652), pulmonary hypertension (K252360) and cardiac amyloidosis (K253801), delivered as a notification in the EHR. The vendor says CPT III codes make it eligible for reimbursement. A pragmatic trial of its decision support tool is listed in Am Heart J Plus 2026, and many Anumana papers have Mayo or nference authors. Bayesian Health's sepsis device (K250680, April 2026) monitors EHR data continuously and shows a Sepsis Risk High flag for adults. The 2022 Nature Medicine study covered 764,707 encounters in five hospitals, but it studied the TREWS system the device descends from, and whether the cleared flag matches that version is open. The 18% lower in-hospital mortality when alerts were acted on is the vendor's observational claim. From October 2026 Medicare's add-on payment gives a hospital up to $61.84 per eligible fee-for-service inpatient case. A cardiology department catching low ejection fraction on routine ECGs buys Anumana, and a sepsis committee flagging inpatients buys Bayesian.